Benítez J - Search Results

1

A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.

Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Paluch-Shimon S, Kaufman B; SWE-BRCA; Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, Nathanson KL, Rebbeck TR, Jakubowska A, Lubinski J, Jaworska K, Durda K, Gronwald J, Huzarski T, Cybulski C, Byrski T, Osorio A, Cajal TR, Stavropoulou AV, Benítez J, Hamann U; HEBON; Rookus M, Aalfs CM, de Lange JL, Meijers-Heijboer HE, Oosterwijk JC, van Asperen CJ, Gómez García EB, Hoogerbrugge N, Jager A, van der Luijt RB; EMBRACE; Easton DF, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Izatt L, Eeles R, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Tischkowitz M, Godwin AK, Pathak H; GEMO Study Collaborators; Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S, Barjhoux L, Léoné M, Gauthier-Villars M, Caux-Moncoutier V, de Pauw A, Hardouin A, Berthet P, Dreyfus H, Ferrer SF, Collonge-Rame MA, Sokolowska J, Buys S, Daly M, Miron A, Terry MB, Chung W, John EM, Southey M, Goldgar D, Singer CF, Tea MK, Gschwantler-Kaulich D, Fink-Retter A, Hansen TV, Ejlertsen B, Johannsson OT, Offit K, Sarrel K, Gaudet MM, Vijai J, Robson M, Piedmonte MR, Andrews L, Cohn D, DeM… See abstract for full author list ➔ Ding YC, et al. Among authors: benitez j. Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1362-70. doi: 10.1158/1055-9965.EPI-12-0229. Epub 2012 Jun 22. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22729394 Free PMC article.

2

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.

de la Hoya M, Osorio A, Godino J, Sulleiro S, Tosar A, Perez-Segura P, Fernandez C, Rodríguez R, Díaz-Rubio E, Benítez J, Devilee P, Caldés T. de la Hoya M, et al. Among authors: benitez j. Int J Cancer. 2002 Feb 1;97(4):466-71. doi: 10.1002/ijc.1627. Int J Cancer. 2002. PMID: 11802208 Free article.

3

Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer.

Osorio A, de la Hoya M, Rodríguez-López R, Martínez-Ramírez A, Cazorla A, Granizo JJ, Esteller M, Rivas C, Caldés T, Benítez J. Osorio A, et al. Among authors: benitez j. Int J Cancer. 2002 May 10;99(2):305-9. doi: 10.1002/ijc.10337. Int J Cancer. 2002. PMID: 11979449 Free article.

4

Clustering of cancer-related mutations in a subset of BRCA1 alleles: a study in the Spanish population.

de la Hoya M, Sulleiro S, Osorio A, Díez O, Baiget M, Benítez J, Díaz-Rubio E, Caldés T. de la Hoya M, et al. Among authors: benitez j. Int J Cancer. 2002 Aug 10;100(5):618-9. doi: 10.1002/ijc.10527. Int J Cancer. 2002. PMID: 12124814 Free article.

5

No mutations in the XRCC2 gene in BRCA1/2-negative high-risk breast cancer families.

Rodríguez-López R, Osorio A, Sánchez-Pulido L, De La Hoya M, Barroso A, Caldés T, Benítez J. Rodríguez-López R, et al. Among authors: benitez j. Int J Cancer. 2003 Jan 1;103(1):136-7. doi: 10.1002/ijc.10766. Int J Cancer. 2003. PMID: 12455067 Free article. No abstract available.

6

Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain.

Campos B, Díez O, Odefrey F, Domènech M, Moncoutier V, Martínez-Ferrandis JI, Osorio A, Balmaña J, Barroso A, Armengod ME, Benítez J, Alonso C, Stoppa-Lyonnet D, Goldgar D, Baiget M. Campos B, et al. Among authors: benitez j. Hum Mutat. 2003 Apr;21(4):452. doi: 10.1002/humu.9133. Hum Mutat. 2003. PMID: 12655574

7

Over-representation of two specific haplotypes among chromosomes harbouring BRCA1 mutations.

Osorio A, de la Hoya M, Rodríguez-López R, Granizo JJ, Díez O, Vega A, Durán M, Carracedo A, Baiget M, Caldés T, Benítez J. Osorio A, et al. Among authors: benitez j. Eur J Hum Genet. 2003 Jun;11(6):489-92. doi: 10.1038/sj.ejhg.5200969. Eur J Hum Genet. 2003. PMID: 12774043

8

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, Rodríguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Sánchez L, Rivas C, Benítez J. Palacios J, et al. Among authors: benitez j. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3606-14. Clin Cancer Res. 2003. PMID: 14506147

9

The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population.

Osorio A, Rodríguez-López R, Díez O, de la Hoya M, Ignacio Martínez J, Vega A, Esteban-Cardeñosa E, Alonso C, Caldés T, Benítez J. Osorio A, et al. Among authors: benitez j. Int J Cancer. 2004 Jan 1;108(1):54-6. doi: 10.1002/ijc.11414. Int J Cancer. 2004. PMID: 14618615 Free article.

10

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

Palacios J, Honrado E, Osorio A, Diez O, Rivas C, Benítez J. Palacios J, et al. Among authors: benitez j. J Natl Cancer Inst. 2004 May 5;96(9):712-4; author reply 714. doi: 10.1093/jnci/djh115. J Natl Cancer Inst. 2004. PMID: 15126609 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,641 results

Search Page